Biomerica (BMRA) EBT Margin (2010 - 2026)
Biomerica recorded quarterly EBT Margin of 132.12% in Q1 2026, down 21.57% quarter-over-quarter from 108.68% in Q4 2025, and down 2783.0% year-over-year from 4.92% in Q1 2025.
Biomerica's EBT Margin history runs 17 years deep, the most recent figure standing at 132.12% for Q1 2026.
- In Q1 2026, EBT Margin fell 2783.0% year-over-year to 132.12%; the TTM figure through Feb 2026 stood at 96.0% (down 1065.0% YoY), while the FY2025 annual figure was 93.62%, up 1600.0% from the prior year.
- EBT Margin came in at 132.12% for Q1 2026 at Biomerica, down from 108.68% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 0.36% in Q3 2025 to a low of 205.47% in Q2 2025.
- A 5-year average of 101.92% and a median of 108.68% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin jumped 12921 bps in 2022 and plunged 14404 bps in 2023, its largest moves.
- Biomerica's EBT Margin stood at 109.65% in 2022, then increased by 13 bps to 95.66% in 2023, then soared by 39 bps to 58.25% in 2024, then slumped by 87 bps to 108.68% in 2025, then decreased by 22 bps to 132.12% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 132.12%, 108.68%, and 0.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | -132.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -132.12% |
| Nov 30, 2025 | -108.68% |
| Aug 31, 2025 | 0.36% |
| May 31, 2025 | -205.47% |
| Feb 28, 2025 | -104.29% |
| Nov 30, 2024 | -58.25% |
| Aug 31, 2024 | -72.61% |
| May 31, 2024 | -126.70% |
| Feb 29, 2024 | -188.20% |
| Nov 30, 2023 | -95.66% |
| Aug 31, 2023 | -64.74% |
| May 31, 2023 | -160.56% |
| Feb 28, 2023 | -145.36% |
| Nov 30, 2022 | -109.65% |
| Aug 31, 2022 | -126.45% |
| May 31, 2022 | -32.99% |
| Feb 28, 2022 | -1.32% |
| Nov 30, 2021 | -24.16% |
| Aug 31, 2021 | -121.52% |
| May 31, 2021 | -162.20% |
| Feb 28, 2021 | -58.63% |
| Nov 30, 2020 | -124.20% |
| Aug 31, 2020 | -144.08% |
| May 31, 2020 | -29.99% |
| Feb 29, 2020 | -73.15% |
| Nov 30, 2019 | -30.40% |
| Aug 31, 2019 | -42.32% |
| May 31, 2019 | -65.28% |
| Feb 28, 2019 | -53.82% |
| Nov 30, 2018 | -31.80% |
| Aug 31, 2018 | -35.49% |
| May 31, 2018 | -56.25% |
| Feb 28, 2018 | -23.44% |
| Nov 30, 2017 | -16.65% |
| Aug 31, 2017 | -14.33% |
| May 31, 2017 | -23.86% |
| Feb 28, 2017 | -20.28% |
| Nov 30, 2016 | -14.17% |
| Aug 31, 2016 | -3.93% |
| May 31, 2016 | -20.20% |
| Feb 29, 2016 | -19.10% |
| Nov 30, 2015 | -16.80% |
| Aug 31, 2015 | -5.62% |
| May 31, 2015 | -3.70% |
| Feb 28, 2015 | -10.30% |
| Nov 30, 2014 | -21.00% |
| Aug 31, 2014 | -21.20% |
| May 31, 2014 | -3.06% |
| Feb 28, 2014 | 2.42% |
| Nov 30, 2013 | -26.03% |
| Aug 31, 2013 | -16.54% |
| May 31, 2013 | 1.30% |
| Feb 28, 2013 | -3.97% |
| Nov 30, 2012 | 13.20% |
| Aug 31, 2012 | 18.39% |
| May 31, 2012 | 6.07% |
| Feb 29, 2012 | 13.67% |
| Nov 30, 2011 | 12.07% |
| Aug 31, 2011 | 8.37% |
| May 31, 2011 | 8.07% |
| Feb 28, 2011 | 5.45% |
| Nov 30, 2010 | -15.28% |